Enhancing immune cell trafficking to brain tumors: Recent advances and therapeutic strategies
Neuro-Oncology · 01.08.2026 · 28 (8) · 1840-1860
DOI: 10.1093/neuonc/noag075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 03.04.2026. Verfasst von Zhuoqi Tong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Cell Movement, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, Focused Ultrasound Foundation.
Abstract (Originalsprache)
For peripheral immune cells to be effective against brain tumors, multiple coordinated steps are required, including migration and homing to the local microenvironment—collectively referred to as immune cell trafficking—followed by survival, proliferation, and persistence, all while remaining functional. This review focuses on the often-overlooked first step, trafficking, which is critical for initiating subsequent processes and driving antitumor responses. We summarize the migration cascade of immune cells, including T cells and macrophages, across the blood-brain barrier (BBB) and how primary brain tumors as well as brain metastases alter the molecular pathways and interactions associated with the immune cell migration cascade across the BBB and their functional homing. Subsequently, we highlight recent developments in engineering biomolecular, cellular, and physical methods to modulate the tumor microenvironment and improve the functional trafficking of immune cells in brain tumors. Our analysis reveals novel combinations to potentiate antitumor responses via feedforward mechanisms and modular therapeutic strategies designed to improve the migration and accumulation of functional immune cells in brain tumors. A deeper understanding of immune cell trafficking, distribution, and homing through the application of preclinical and clinical imaging techniques along with the development of in vitro/ex vivo platforms should enable new and more potent immunotherapy strategies against primary brain malignancies and brain metastases as well as accelerate their translation to the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University Atlanta, Georgia, USA.
- Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA (C.K., C.A.).
- Center for Brain Immunology and Glia, Neuroscience Department, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
- Department of Neuroscience, University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, USA (J.L.R.).
ORCID-Profile: Zhuoqi Tong, Chulyong Kim, James L Ross, Costas Arvanitis
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
- Focused Ultrasound Foundation
- NSF
- University of Virginia Comprehensive Cancer Center
- The Cure Starts Now
- University of Virginia Brain Immunology and Glia Center
- National Institute of Health
Zitieren
APA
Tong, Z., Kim, C., Ross, J. L., & Arvanitis, C. (2026). Enhancing immune cell trafficking to brain tumors: Recent advances and therapeutic strategies. Neuro-Oncology, 28(8), 1840-1860. https://doi.org/10.1093/neuonc/noag075
Vancouver
Tong Z, Kim C, Ross JL, Arvanitis C. Enhancing immune cell trafficking to brain tumors: Recent advances and therapeutic strategies. Neuro-Oncology. 2026;28(8):1840-1860. doi:10.1093/neuonc/noag075
BibTeX
@article{Tong2026,
author = {Tong, Zhuoqi and Kim, Chulyong and Ross, James L and Arvanitis, Costas},
title = {Enhancing immune cell trafficking to brain tumors: Recent advances and therapeutic strategies},
journal = {Neuro-Oncology},
year = {2026},
volume = {28},
number = {8},
pages = {1840--1860},
doi = {10.1093/neuonc/noag075}
}
EUVIMED